Custom Antibody Services

Learn More


Learn More

Recombinant vs. Traditional Antibodies

Learn More


Introducing MembraneProSelect™! Rapid development of monoclonal antibodies in 6-7 weeks!

Technology Corner

  Rapid Liquid Screening

Rapid Liquid Screening is the automated, all-liquid biopanning methodology developed by AxioMx. It enables quick screening of recombinant antibody phage display libraries against a target antigen, allowing the best binders to that antigen to be selected.

Read More

News and Events

  AxioMx Awarded SBIR Grant for Rapid scFv-to-IgG Conversion

Branford, Conn. – October 13, 2015. AxioMx announced that it has received a Phase I Small Business Innovative Researc...

Read More
  AxioMx Launches AxioMx MembraneProSelect™ Service

September 22, 2015. AxioMx announced the launch of AxioMx MembraneProSelect™, a new service that enables the developme...

Read More

Request Services Quotation

Request Now

Join Our Mailing List

Sign up and stay up to date on the latest news from AxioMx.

Sign up now